Breast cancer Flashcards
what are the risk factors for breast cancer
age, early onset of menstruation, late menopause and older age of pregnancy, fh of breast cancer, obesity and alcohol consumption
Medications that increase risk of breast cancer
oral contraceptives and HRT
What can protect against breast cancer
physical activity and breast feeding
types of treatment for breast cancer
Chemotherapy endocrine therapy biological therapy bisphosphonate therapy suregy to breast with or without radiotherapy follwed by adjuvant therapy based on risk and benefits and hormone receptors. adjuvants are above
what is the name of the chemo used for invasive breast cancer
anthracycline-taxane combination combination is recommended in pts with invasive breast cancer who are at risk of reoccurrence and chemotherapy
what is teh name of the biological therapyfor breast cancer. when is it used? what needs to be monitored alonside this
For tumour size T1C and above HER2 positive invasive breast cancer trastuzumab is used
also for small tumour size
cardiac function should be assessed throughput and caution in pts with underlying cardiac disease
what medication should be used in men and pre menoupausal women with oestrogen receptor positive invasive breast cancer
tamoxifen as adjuvant endocrine therapy before chemo
what mendication should be used in post menopausal women with oestrogen positive invasive breast cancer invasive breast cancer who are high ror medium risk of reoccurrence
aromatase inhibitor
Tamoxifen i fthis is contra-indicated
which drugs have been shown to improve disease free survival and overall survival in postmenopausal women with node positive invasive breast cancer
zolendronic acid and sodium clodronate
for pts with oestrogen receptor negative breast cancer what should be used to reduce tumour size
neoadjuvant chemo
in pts with HER2 positive invsaive breast cancer what should be used
neoadjuvant alongside tratuzumab and pertuzumab
what meds should be used for triple negative invasive breast cancer
platinum and an anthracycline
if pt oestrogen receptor positive advanced breast cancer
endocrine therapy first line
post menopausal with no hostory of endocrine treatment or those previously treated with tamoxifen what is used
aromatase ihibotors
for pre and perimenopausal wone with oestrogen receptor posistive advanced breast cancer not treated with tamoxifen what should be used
tamoxifen and ovarian supression